Vivo Opportunity Fund Holdings, L.P.

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol
ANTX on Nasdaq
Investment type
Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned
2,864,346 shares
Security Ownership %
8%

Vivo Opportunity Fund Holdings, L.P. ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

13 Mar 2026 - Vivo Opportunity Fund Holdings, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,864,346 shares of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX). This represents 8% ownership of the company. This is the first filing by Vivo Opportunity Fund Holdings, L.P. disclosing ownership of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX).